The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study
ABSTRACT Objective: Ventilator-associated pneumonia (VAP) is the leading type of hospital-acquired infection in ICU patients. The diagnosis of VAP is challenging, mostly due to limitations of the diagnostic methods available. The aim of this study was to determine whether antibody-coated bacteria (ACB) evaluation can improve the specificity of endotracheal aspirate (EA) culture in VAP diagnosis. Methods: We conducted a diagnostic case-control study, enrolling 45 patients undergoing mechanical ventilation. Samples of EA were obtained from patients with and without VAP (cases and controls, respectively), and we assessed the number of bacteria coated with FITC-conjugated monoclonal antibodies (IgA, IgM, or IgG) or an FITC-conjugated polyvalent antibody. Using immunofluorescence microscopy, we determined the proportion of ACB among a fixed number of 80 bacteria. Results: The median proportions of ACB were significantly higher among the cases (n = 22) than among the controls (n = 23)-IgA (60.6% vs. 22.5%), IgM (42.5% vs. 12.5%), IgG (50.6% vs. 17.5%), and polyvalent (75.6% vs. 33.8%)-p < 0.001 for all. The accuracy of the best cut-off points for VAP diagnosis regarding monoclonal and polyvalent ACBs was greater than 95.0% and 93.3%, respectively. Conclusions: The numbers of ACB in EA samples were higher among cases than among controls. Our findings indicate that evaluating ACB in EA is a promising tool to improve the specificity of VAP diagnosis. The technique could be cost-effective and therefore useful in low-resource settings, with the advantages of minimizing false-positive results and avoiding overtreatment.
Main Authors: | , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Pneumologia e Tisiologia
2016
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132016000300203 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1806-37132016000300203 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1806-371320160003002032016-06-29The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control studyRanzani,Otavio TavaresForte,Daniel NevesForte,Antonio CarlosMimica,IgorForte,Wilma Carvalho Neves Pneumonia, ventilator-associated/diagnosis Immunohistochemistry Fluorescent antibody technique Antibodies, bacterial/analysis Trachea/microbiology Intensive care units ABSTRACT Objective: Ventilator-associated pneumonia (VAP) is the leading type of hospital-acquired infection in ICU patients. The diagnosis of VAP is challenging, mostly due to limitations of the diagnostic methods available. The aim of this study was to determine whether antibody-coated bacteria (ACB) evaluation can improve the specificity of endotracheal aspirate (EA) culture in VAP diagnosis. Methods: We conducted a diagnostic case-control study, enrolling 45 patients undergoing mechanical ventilation. Samples of EA were obtained from patients with and without VAP (cases and controls, respectively), and we assessed the number of bacteria coated with FITC-conjugated monoclonal antibodies (IgA, IgM, or IgG) or an FITC-conjugated polyvalent antibody. Using immunofluorescence microscopy, we determined the proportion of ACB among a fixed number of 80 bacteria. Results: The median proportions of ACB were significantly higher among the cases (n = 22) than among the controls (n = 23)-IgA (60.6% vs. 22.5%), IgM (42.5% vs. 12.5%), IgG (50.6% vs. 17.5%), and polyvalent (75.6% vs. 33.8%)-p < 0.001 for all. The accuracy of the best cut-off points for VAP diagnosis regarding monoclonal and polyvalent ACBs was greater than 95.0% and 93.3%, respectively. Conclusions: The numbers of ACB in EA samples were higher among cases than among controls. Our findings indicate that evaluating ACB in EA is a promising tool to improve the specificity of VAP diagnosis. The technique could be cost-effective and therefore useful in low-resource settings, with the advantages of minimizing false-positive results and avoiding overtreatment.info:eu-repo/semantics/openAccessSociedade Brasileira de Pneumologia e TisiologiaJornal Brasileiro de Pneumologia v.42 n.3 20162016-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132016000300203en10.1590/S1806-37562015000000244 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Ranzani,Otavio Tavares Forte,Daniel Neves Forte,Antonio Carlos Mimica,Igor Forte,Wilma Carvalho Neves |
spellingShingle |
Ranzani,Otavio Tavares Forte,Daniel Neves Forte,Antonio Carlos Mimica,Igor Forte,Wilma Carvalho Neves The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study |
author_facet |
Ranzani,Otavio Tavares Forte,Daniel Neves Forte,Antonio Carlos Mimica,Igor Forte,Wilma Carvalho Neves |
author_sort |
Ranzani,Otavio Tavares |
title |
The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study |
title_short |
The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study |
title_full |
The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study |
title_fullStr |
The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study |
title_full_unstemmed |
The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study |
title_sort |
value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study |
description |
ABSTRACT Objective: Ventilator-associated pneumonia (VAP) is the leading type of hospital-acquired infection in ICU patients. The diagnosis of VAP is challenging, mostly due to limitations of the diagnostic methods available. The aim of this study was to determine whether antibody-coated bacteria (ACB) evaluation can improve the specificity of endotracheal aspirate (EA) culture in VAP diagnosis. Methods: We conducted a diagnostic case-control study, enrolling 45 patients undergoing mechanical ventilation. Samples of EA were obtained from patients with and without VAP (cases and controls, respectively), and we assessed the number of bacteria coated with FITC-conjugated monoclonal antibodies (IgA, IgM, or IgG) or an FITC-conjugated polyvalent antibody. Using immunofluorescence microscopy, we determined the proportion of ACB among a fixed number of 80 bacteria. Results: The median proportions of ACB were significantly higher among the cases (n = 22) than among the controls (n = 23)-IgA (60.6% vs. 22.5%), IgM (42.5% vs. 12.5%), IgG (50.6% vs. 17.5%), and polyvalent (75.6% vs. 33.8%)-p < 0.001 for all. The accuracy of the best cut-off points for VAP diagnosis regarding monoclonal and polyvalent ACBs was greater than 95.0% and 93.3%, respectively. Conclusions: The numbers of ACB in EA samples were higher among cases than among controls. Our findings indicate that evaluating ACB in EA is a promising tool to improve the specificity of VAP diagnosis. The technique could be cost-effective and therefore useful in low-resource settings, with the advantages of minimizing false-positive results and avoiding overtreatment. |
publisher |
Sociedade Brasileira de Pneumologia e Tisiologia |
publishDate |
2016 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132016000300203 |
work_keys_str_mv |
AT ranzaniotaviotavares thevalueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy AT fortedanielneves thevalueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy AT forteantoniocarlos thevalueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy AT mimicaigor thevalueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy AT fortewilmacarvalhoneves thevalueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy AT ranzaniotaviotavares valueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy AT fortedanielneves valueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy AT forteantoniocarlos valueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy AT mimicaigor valueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy AT fortewilmacarvalhoneves valueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy |
_version_ |
1756431071197528064 |